Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Dyal

Interventional Cardiology Miami, FL Medical Doctor

NPI 1669649539 CMS profile 347551

1201 Nw 16Th St Ste C1008, Miami, FL 33125

Open in the dashboard

General payments

$156,949

185 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Dyal of Miami, FL is reported in the CMS Open Payments database as having received $156,949 across 185 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,010 26
2024 General $56,038 58
2023 General $39,853 41
2022 General $19,858 34
2021 General $7,817 8
2020 General $3,577 6
2019 General $796 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Dyal
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Michael Dyal were reported at $29,010. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Michael Dyal Interventional Cardiology median Middle half National median
2019 $796 $1,097 $329–$3,048 $163
2020 $3,577 $473 $161–$1,480 $114
2021 $7,817 $677 $233–$1,827 $132
2022 $19,858 $978 $333–$2,724 $149
2023 $39,853 $1,136 $382–$2,986 $160
2024 $56,038 $1,181 $395–$3,326 $164
2025 $29,010 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Philips Electronics North America Corporation $76,187 34 payments
  2. Abbott Laboratories $64,953 84 payments
  3. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $9,500 4 payments
  4. Boston Scientific Corporation $3,702 30 payments
  5. Edwards Lifesciences Corporation $478 4 payments
  6. Impulse Dynamics (USA) Inc. $436 4 payments
  7. Inari Medical, Inc. $420 5 payments
  8. Medtronic, Inc. $347 5 payments
  9. Medtronic Vascular, Inc. $343 6 payments
  10. LivaNova USA, Inc. $148 2 payments
  11. Other $436 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $62,675 13 payments
  2. Honoraria $61,325 17 payments
  3. Travel and Lodging $22,170 50 payments
  4. Food and Beverage $7,379 102 payments
  5. Education $3,400 3 payments
Products named General payments · program years 2019–2025
  1. AMPLATZER AMULET $62,333 74 payments
  2. (7881) US Und $36,902 13 payments
  3. IGT Devices Undivided $17,493 5 payments
  4. (6361) Core Mobile $11,975 2 payments
  5. LifeVest $9,500 4 payments
  6. (1399) MRI Equip Undiv $3,400 3 payments
  7. VersaCross Access Solution $2,717 12 payments
  8. US EQ Undivided $2,500 1 payment
  9. (7881) Ultrasound Und $2,125 1 payment
  10. JETI ALL IN ONE NON-STERILE KIT $1,750 1 payment
  11. Other $6,746 75 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

185 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record